Related references
Note: Only part of the references are listed.Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
Ilias Karaiskos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii
Chui-Yoke Chin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
Rebekah Henry et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol
Nusaibah Abdul Rahim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
InterProScan 5: genome-scale protein function classification
Philip Jones et al.
BIOINFORMATICS (2014)
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2014)
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
Zakuan Z. Deris et al.
JOURNAL OF ANTIBIOTICS (2014)
Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model
George Louis Drusano et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)
Ronald N. Jones et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea
So Yeon Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G. Zhanel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
Timothy R. Sampson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Zakuan Z. Deris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010)
Ana C. Gales et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
Luis A. Arroyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems
Kim-Anh Le Cao et al.
BMC BIOINFORMATICS (2011)
Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii
Young Kyoung Park et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Resistance to polymyxins: Mechanisms, frequency and treatment options
Matthew E. Falagas et al.
DRUG RESISTANCE UPDATES (2010)
Structure-Activity Relationships of Polymyxin Antibiotics
Tony Velkov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool
Laure Diancourt et al.
PLOS ONE (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
Mark D. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Colistin in the 21st century
Roger L. Nation et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
Looming Global-Scale Failures and Missing Institutions
Brian Walker et al.
SCIENCE (2009)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Mark D. Adams et al.
JOURNAL OF BACTERIOLOGY (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
John D. F. Hale et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
OrthoMCL: Identification of ortholog groups for eukaryotic genomes
L Li et al.
GENOME RESEARCH (2003)
Inorganic polyphosphate is essential for long-term survival and virulence factors in Shigella and Salmonella spp.
KS Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
AC Gales et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa
LJ Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
